A Response to the Letter to the Editor: "Lazertinib Versus Osimertinib in EGFR-Mutant NSCLC: Efficacy, Toxicity, and Unaddressed Clinical Gaps

  • Lee, Se-Hoon; 
  • Lu, Shun; 
  • Yang, James Chih-Hsin; 
  • Shah, Sujay; 
  • Sethi, Seema; 
  • 외 1명
Citations

WEB OF SCIENCE

0
Citations

SCOPUS

0
제목
A Response to the Letter to the Editor: "Lazertinib Versus Osimertinib in EGFR-Mutant NSCLC: Efficacy, Toxicity, and Unaddressed Clinical Gaps
저자
Lee, Se-Hoon; Lu, Shun; Yang, James Chih-Hsin; Shah, Sujay; Sethi, Seema; Cho, Byoung Chul
DOI
10.1016/j.jtho.2025.08.007
발행일
2026-01
유형
Letter
저널명
Journal of Thoracic Oncology
권
21
호
1
페이지
199 ~ 200